Abstract:OBJECTIVE:To establish a simple, rapid and economical method in detecting mutations of oncogene K-ras and to investigate its mutations in colorectal cancer tissues and its relationship with clinicopathologic characteristics of colorectal carcinoma.METHODS:Forty colorectal cancer tissues were tested for K-ras mutations at codon 12 and codon 13 using polymerase chain reaction (PCR) followed by direct sequencing and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) followed by sequence analysis. The other 113 colorectal cancer tissues were tested for K-ras mutations at codon 12 and codon 13 using PCR-RFLP followed by sequence analysis only. The mutation results were analyzed with the corresponding clinical pathological data.RESULTS:Among 40 colorectal cancer cases, none of K-ras mutations at codon 12 and codon 13 was detected by PCR followed by direct sequencing. However, K-ras mutations were found in 11 cases (11/40, 27.5%) by PCR-RFLP followed by sequence analysis, including 8 cases at codon 12 and 3 cases at codon 13 respectively. Among 153 colorectal cancer cases, point mutations were detected by PCR-RFLP followed by sequence analysis in 58 cases (37.9%). Point mutations at codon 12 were found in 46 cases and 12 cases at codon 13. Mutations with the highest frequency were G→A transitions (25/58, 43.1%) at codon 12. No significant correlation was observed between mutations of K-ras and gender, invasive depth, tumor differentiation, number of invaded lymph nodes, distant metastasis and clinical stage (P > 0.05). Mutation of oncogene K-ras at codon 12 and codon 13 was closely related with age and tumor location (P < 0.05). The incidence of K-ras mutation was significantly higher in younger patients and in patients with ascending colon cancer.CONCLUSIONS:PCR-RFLP followed by sequence analysis is a rapid, simple, sensitive and low-cost method. It is a suitable technology for detecting hot-spot mutations in the K-ras oncogene. Mutation of oncogene K-ras at codon 12 and codon 13 is a common molecular event in colorectal carcinogenesis, which might be related with age and tumor location.

Detection of K-ras Mutation in Colorectal Cancer and Its Clinicopathological Significance

Values of Mutations of K-ras Oncogene at Codon 12 in Detection of Pancreatic Cancer: 15-Year Experience

[K-Ras Gene Mutation in Colorectal Cancer and Its Clinicopathologic Significance].

The relationship between K-ras gene mutation with clinicopathological and prognosis in gallbladder carcinoma

Relationship Between K-ras Mutational Status and Clinical Pathological Characteristics in Colorectal Cancer

KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?

Detection of KRAS Gene Mutation and Its Clinical Significance in Colorectal Adenocarcinoma

Detection of KRAS mutations and their associations with clinicopathological features and survival in Chinese colorectal cancer patients.

Detection of K-ras mutation in advanced colorectal carcinoma by Pyrosequencing

Detection Of Kras Gene Mutations In Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy For Improving Pancreatic Cancer Diagnosis

Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients with Metastatic Colorectal Cancer.

[Study on relationship of the K-ras mutation with the occurrence of colorectal liver metastasis and survival outcomes].

Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.

Mutations in Epidermal Growth Factor Receptor and K-ras in Chinese Patients with Colorectal Cancer

K-ras status and efficacy of cetuximab-containing regimen in the treatment of patients with metastatic colorectal cancer

Mutation Detection of K-ras Gene in Paraffin-Embedded Colorectal Cancer Tissues by Using Chip-Based TGCE

KRAS Mutation Testing in Metastatic Colorectal Cancer.

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer.

Mutations of KRAS and BRAF in Chinese Patients with Colorectal Carcinoma : Analyses of 966 Cases

K-Ras Gene Mutation in the Diagnosis of Ultrasound Guided Fine-Needle Biopsy of Pancreatic Masses

Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue